Released on 2025-04-02

PRECISESADS: Cross Sectional Study Data

Accession number

ELU-2-ECD933-1

Description

Aggregated data containing RNAseq, antibodies, cell populations, cytokines and inflammatory analytes from healthy donors and SLE patients. Dataset provided as anonymized.

Request Data Access

Export Metadata as DATS

Project

Project Title: PRECISESADS Sustainability at ELIXIR LU
Project website: https://www.imi.europa.eu/projects-results/project-factsheets/precisesads

Studies

Study title: PRECISESADS: Cross Sectional Study - Lupus patients and healthy donors

General Dataset Information

Version: V1.0
Created on: -
Updated on: -
Experiment types: clinical data RNASeq Other
Type of Samples Collected: Whole blood
Number of Samples Collected: 839
Diseases in samples: Systemic Lupus Erythematosus (SLE)
Treatment or experiment categories: Transcriptomics Serology profiling Flow cytometry profiling

Dataset contacts

Data owner: -
Main contact: Marta Alarcón Riquelme
Email: marta.alarcon@genyo.es
Affiliation: Fundación Pública Andaluza Progreso y Salud

Use restrictions

Constrained permissions

Use Restriction	Remarks	Category (GA4GH)
Use is limited to research in the field of systemic auto immune diseases (SADS)	Limited scope of research. Is data consented to be used only in specific research/disease areas? E.g. use only in Biomedical Research.	Disease-specific Research and Clinical Care. (DS)
Use is limited to non-commercial scientific research project and publication purposes. Such non-commercial use by a commercial entity is permitted.		Not-for-profit Use Only (NPU)

Obligations

Use Restriction	Remarks	Category (GA4GH)
To acknowledge the origin of the data being used, please mention the PRECISESADS Consortium: This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking PRECISESADS grant n° 115565. Where reasonable consider if partners of PRECISESADS may be co-authors.	Publication requirements Are there any requirements in case of publications based on the DATA? E.g. papers should cite the cohort study.	Publication Required (PUB)
Acknowledgement of the ELIXIR Luxembourg by following statement is required in all publications resulting from any analyses of the data: "This work was supported by ELIXIR Luxembourg"	Acknowledgement of the ELIXIR Luxembourg is required in all publications based on the data provided.	Publication Required (PUB)